Report Feature
The future of the molecule diagnostic market looks promising with opportunities in the reference laboratories, and hospital/academic laboratories. The global molecule diagnostic market is expected to
grow with a CAGR of 9% from 2019 to 2024. The major drivers for this market are high prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostic, growth in the biomarker identification market and advancements in molecular techniques, and reforms in the reimbursement system in the US.A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of benefits, companies researched and other details of molecule diagnostics market report download the report brochure
The study includes the molecule diagnostics market size and forecast for the global molecule diagnostics market through 2024, segmented by product and services, application, technology, end user, and by region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
- Assays and Kits
- Instruments/Analyzers
- Services and Software
By Application [$M shipment analysis for 2013 – 2024]:
- Infectious Diseases
- Oncology
- Genetic Tests
- Blood Screening
- Microbiology
- Others
By Technology [$M shipment analysis for 2013 – 2024]:
- RT-PCR
- INAAT
- DNA Sequencing & NGS
- In Situ Hybridization
- DNA Microarrays
- Others
By End User [$M shipment analysis for 2013 – 2024]:
- Reference Laboratories
- Hospital/Academic Laboratories
- Others
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia-Pacific
- China
- India
- Japan
-
Rest of the World (ROW)
- Brazil
Some of the molecule diagnostics companies profiled in this report include Abbott Laboratories, Qiagen, Roche Diagnostic, Hologic, Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter, Biomérieux, and Cepheid.
Some of the features of "Global Molecular Diagnostics Market 2019-2024: Trends, Forecast, and Opportunity Analysis" include
- Market size estimates:Global molecule diagnostics market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis:Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis:Global market size by product and services, application, technology, end user, and by region.
- Regional analysis:Global molecule diagnostics market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities:Analysis on growth opportunities in different applications and regions for molecule diagnostics in the global molecule diagnostics market.
- Strategic analysis:This includes M&A, new product development, and competitive landscape for, molecule diagnostics in the global molecule diagnostics market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1: Introduction, Background, and Classifications 2.2: Supply Chain 2.3: Industry Drivers and Challenges
5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter’s Five Forces Analysis
7. Company Profiles of Leading Players 7.1: Abbott Laboratories 7.2: Qiagen 7.3: Roche Diagnostics 7.4: Hologic 7.5: Grifols 7.6: Siemens Healthcare 7.7: Becton, Dickinson And Company 7.8: Beckman Coulter 7.9: Biomérieux
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global molecule diagnostic market by product & service (assays and kits, instruments/analyzers, and services & software) application (infectious diseases, oncology, genetic tests, blood screening, microbiology and others), technology (RT-PCR, INAAT, others), end user (reference laboratories, hospital/academic laboratories and others), and region (North America, Europe, Asia-Pacific and Rest of the World (ROW))?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the molecule diagnostic market?
- • What are the business risks and threats to the molecule diagnostic market?
- • What are emerging trends in this molecule diagnostic market and the reasons behind them?
- • What are some changing demands of customers in the molecule diagnostic market?
- • What are the new developments in the molecule diagnostic market? Which companies are leading these developments?
- • Who are the major players in this molecule diagnostic market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this molecule diagnostic area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in this, molecule diagnostic market?
